Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

 

Search in our Online Store

Generics
Filter     Order     Display # 
Date Item Title Hits
11 Mar 2010 AstraZeneca Extends Branded Generics Capability With Torrent Agreement 173
22 Feb 2010 Watson Files FDA Application for Generic Aplenzin(TM) ER 207
08 Feb 2010 Sagent Pharmaceuticals Announces FDA Approval of Labetalol Hydrochloride Injection, USP 112
04 Feb 2010 Aurobindo Pharma receives final approval for Cetirizine Hydrochloride Solution (OTC) 135
02 Feb 2010 Teva Announces FDA Accepts BLA for XM02 172
02 Feb 2010 Taro Receives FDA Approval for Levetiracetam Tablets 90
26 Jan 2010 FDA Approves Morphine Sulfate Oral Solution for Relief of Acute and Chronic Pain 143
21 Jan 2010 Teva Announces Tentative Approval of Generic Femara Tablets 130
19 Jan 2010 Watson Confirms Filing of FDA Application for Generic Lidoderm(R) 222
08 Jan 2010 Watson Files FDA Application for Generic LoSeasonique(R) 193
06 Jan 2010 Watson Files FDA Application for Generic Nuvigil(R) 176
04 Dec 2009 Watson Files FDA Application for Generic Rozerem(R) 299
01 Dec 2009 Teva Announces the Submission of a Biologics License Application (BLA) for XM02 for the Treatment of Chemotherapy-Induced Neutropenia 305
18 Nov 2009 Teva Launches TevaGrastim(R) (filgrastim) 264
08 Oct 2009 APP Pharmaceuticals Receives Approval for Sumatriptan Succinate Injection, USP 302
08 Oct 2009 Hospira, Celltrion, Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs 326
05 Oct 2009 Sandoz launches somatropin, the first-ever Japanese biosimilar, increasing access to key medicines in second largest global market 133
05 Oct 2009 Impax Laboratories Receives Tentative FDA Approval for Generic FLOMAX(R) 0.4mg Capsules 268
30 Sep 2009 Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim and Manufacturing Facility From PLIVA 368
30 Sep 2009 Mylan Receives FDA Approval for Generic Version of Parkinson's Treatment Sinemet(R) 162
22 Sep 2009 Protalix Reports Preclinical Data on Anti-TNF Follow-on Biologic Arthritis Drug 367
18 Sep 2009 Glenmark Generics receives ANDA approval from the U.S. FDA for Verapamil SR tablets 401
17 Sep 2009 APP Pharmaceuticals Receives Approval for Deferoxamine Mesylate for Injection, USP 151
16 Sep 2009 Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR for Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets 180
14 Sep 2009 FDA Accepts for Filing Mylan's ANDA for Generic Copaxone® 122
10 Sep 2009 PAR PHARMACEUTICAL RECEIVES FINAL APPROVAL TO MARKET GENERIC STARLIX® 190
07 Sep 2009 Aurobindo Pharma receives final approval for Risperidone Oral Solution 203
01 Sep 2009 Mylan Launches First Generic Version of Xopenex(R) Inhalation Solution (Concentrate), 0.25% 169
28 Aug 2009 Watson Pharmaceuticals Receives FDA Approval for Generic PLAN B(R) for Over-the-Counter Use 178
27 Aug 2009 Aurobindo Pharma receives final approval for Clindamycin Hydrochloride Capsules from USFDA 148
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 1 - 30 of 523

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Biologic and Immune Therapy of S. aureus Infections

Order Now

Recommended Report

RNA Therapeutics
Order Now

Subscribe La Merie Biologics